# MoonLake Immunotherapeutics (MLTX) - Q1 2026 earnings

Reported May 11, 2026.

| | Reported | Consensus estimate |
| --- | --- | --- |
| Revenue | Not available | Not available |
| EPS | $-0.98 | $-0.91 |

Earnings filing reader: [8-K 0001821586-26-000005](https://www.opencapital.sh/filings/0001821586-26-000005)
Agent-readable filing: [Markdown](https://www.opencapital.sh/filings/0001821586-26-000005.md)
Original filing: [SEC.gov filing index](https://www.sec.gov/Archives/edgar/data/1821586/000182158626000005/0001821586-26-000005-index.htm)
Periodic report: 10-Q - https://www.sec.gov/Archives/edgar/data/1821586/000182158626000007/0001821586-26-000007-index.htm
Canonical page (please cite this URL): https://www.opencapital.sh/stocks/mltx/earnings/q1-2026